MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-24-0011765
Aariva Pharma Private Limited - chemicals in Savli, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.45 Cr
▼ 29% YoY
Net profit · FY 2025
₹4.68 Lakh
Net margin 0.4%
EBITDA · FY 2025
₹34.39 Lakh
EBITDA margin 3.3%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹6.57 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
4
As per MCA filings
About Aariva Pharma Private Limited
Data last updated:
Aariva Pharma Private Limited is a private limited company based in Savli, Gujarat, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 21 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2010PTC062056. Its GSTIN is 24AAICA7677E1ZJ (Gujarat).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Gaurang Rajnikant Shah and Jyotika Gaurang Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Savli, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.45 Cr, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹4.68 Lakh (net margin 0.4%) and EBITDA of ₹34.39 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹6.57 Cr on record.
Aariva Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0011765). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aarivapharma.in.
Company details
CIN U24230GJ2010PTC062056
Registration Number 062056
Incorporation Date 21 August 2010
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-24-0011765
Key People
Gaurang Rajnikant Shah Director Amisha R Shah Additional Director Rakesh Shah Additional Director Recognitions & Rankings of Aariva Pharma
Contact details
Aariva Pharma Private Limited's registered office is in Savli, Gujarat. Its website is aarivapharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSurvey No. 809, Mevli Road Samlaya, Savli, Gujarat, India – 391520
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Aariva Pharma Private Limited, buy the company report.
Comprehensive company report
Aariva Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aariva Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aariva Pharma Private Limited, buy the company report.
Financials of Aariva Pharma Private Limited
FY 2025 filings availableAariva Pharma Private Limited reported revenue of ₹10.45 Cr (down 29% YoY) for FY 2025.
Revenue · FY 2025
₹10.45 Cr ▼ 29%
Net profit · FY 2025
₹4.68 Lakh margin 0.4%
EBITDA · FY 2025
₹34.39 Lakh margin 3.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 29%
3 years · compounded
▼ 28%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 19%
3 years · compounded
▲ 6%
5 years · compounded
▲ 7%
Revenue fell 29% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aariva Pharma Private Limited, buy the company report.
Board of directors of Aariva Pharma Private Limited
Aariva Pharma has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurang Rajnikant Shah | Director | 07 Sep 2012 | 14 Years 2 Months | Current |
| Amisha R Shah | Additional Director | 07 Nov 2014 | 12 Years 0 Months | Current |
| Rakesh Shah Also directs: Glukeros Biotech Private Limited, Rajsha Organics Private Limited | Additional Director | 24 Dec 2018 | 7 Years 10 Months | Current |
| Jyotika Gaurang Shah | Director | 21 Mar 2024 | 2 Years 7 Months | Current |
Auditor
Aariva Pharma Private Limited is audited by AMIN PARIKH & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIN PARIKH & CO | FY 2024 | 100332W |
Shareholding
The shareholding of Aariva Pharma Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aariva Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6.57 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jun 2020 | 100346343 | Others | ₹4.57 Cr | Open | |
| 06 Feb 2015 | 10599901 | Fedral Bank | ₹1 Cr | Open | |
| 29 Jan 2015 | 10599897 | Fedral Bank | ₹1 Cr | Open |
To see the full charge records of Aariva Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Aariva Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aariva Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aariva Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICA7677E1ZJ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aariva Pharma Private Limited, buy the company report.
Recent activity
Aariva Pharma Private Limited has 16 board changes on record since 2010: 10 appointments and 6 cessations. The latest: Hemlata Rajnikant Shah ceased to be Director on 23 Mar 2024.
Charges
A charge with Others of Rs. 457.00 Lakh registered on 16 Jun 2020 with Charge ID 100346343 was modified on 16 Feb 2026.
AGM
Aariva Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aariva Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Hemlata Rajnikant Shah ceased to be Director.
Appointed
Jyotika Gaurang Shah was appointed as Director.
Ceased
Atulbhai Shankarbhai Shah ceased to be Director.
Charges
A charge with Others amounted to Rs. 457.00 Lakh with Charge ID 100346343 was registered on 16 Jun 2020.
Ceased
Bhartiben Atulkumar Shah ceased to be Additional Director.
Ceased
Dhaval Atulkumar Shah ceased to be Additional Director.
Ceased
Rajnikant Rasiklal Shah ceased to be Director.
Appointed
Rakesh Shah was appointed as Additional Director.
Charges
A charge with Fedral Bank amounted to Rs. 100.00 Lakh with Charge ID 10599901 was registered on 06 Feb 2015.
11 earlier events are in the company report.
Frequently asked questions
Aariva Pharma is an active private limited company based in Savli, Gujarat, India. The company works in chemical products, within the chemicals industry. It was incorporated on 21 August 2010 (16+ years old) and is registered under CIN U24230GJ2010PTC062056.
Aariva Pharma has 4 current directors:
- Gaurang Rajnikant Shah - Director
- Amisha R Shah - Additional Director
- Rakesh Shah - Additional Director
- Jyotika Gaurang Shah - Director
The latest financial statements of Aariva Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aariva Pharma is 24AAICA7677E1ZJ, registered in Gujarat.
The CIN (Corporate Identification Number) of Aariva Pharma is U24230GJ2010PTC062056. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aariva Pharma was incorporated on 21 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Hemlata Rajnikant Shah ceased to be Director on 23 Mar 2024. Jyotika Gaurang Shah was appointed as Director on 21 Mar 2024. Atulbhai Shankarbhai Shah ceased to be Director on 27 Sep 2021. Aariva Pharma has 16 board changes on record in total.
Yes, Aariva Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-24-0011765).
Aariva Pharma can be reached through the website aarivapharma.in. Its registered office is in Savli, Gujarat, India.
The registered office of Aariva Pharma is at Survey No. 809, Mevli Road Samlaya, Savli, Gujarat, India – 391520.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages